Figure 3From: High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanomaKaplan-Meier estimates of the impact of MCM3 expression on disease free and melanoma-specific survival in thin melanomas. The impact of low and high MCM3 expression on (a) disease free survival, logrank p = 0.007, and (b) melanoma-specific survival, logrank p = 0.031, in thin melanoma (<= 1 mm).Back to article page